Importance of vancomycin loading doses in intermittent infusion regimens

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Infectious Diseases

Background:

• Delayed achievement of target vancomycin serum concentrations can negatively impact patient outcomes.
• Intermittent vancomycin dosing is common, but achieving therapeutic targets can be challenging.

Purpose of the Study:

• To determine the actual frequency of vancomycin loading dose use in adult patients.
• To evaluate the impact of a vancomycin loading dose on achieving pharmacokinetic/pharmacodynamic (PK/PD) targets.
• To establish an optimal vancomycin loading dose based on individual pharmacokinetic calculations.

Main Methods:

• Retrospective study analyzing vancomycin pharmacokinetic models using two-compartmental analysis.
• Calculation of AUC24 (area under the concentration-time curve over 24 hours) for vancomycin.
• Comparison of AUC24 between patients who received and did not receive a vancomycin loading dose using an unpaired t-test.

Main Results:

• Vancomycin loading doses were administered in only 17.8% of patients.
• Patients receiving a loading dose achieved significantly higher AUC24 (496 vs. 341 mg·h/L).
• The proportion of patients reaching the PK/PD target was substantially higher with a loading dose (87.5% vs. 24.3%).

Conclusions:

• Vancomycin loading dose is critical for rapidly achieving PK/PD targets in adult patients on intermittent therapy.
• Despite its importance, loading doses are infrequently used in clinical practice.
• A routine vancomycin loading dose of 25-30 mg/kg is recommended for adult patients receiving intermittent vancomycin.